Z. Janka

1.4k total citations
53 papers, 1.0k citations indexed

About

Z. Janka is a scholar working on Molecular Biology, Psychiatry and Mental health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Z. Janka has authored 53 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 16 papers in Psychiatry and Mental health and 12 papers in Cellular and Molecular Neuroscience. Recurrent topics in Z. Janka's work include Alzheimer's disease research and treatments (10 papers), Neuroscience and Neuropharmacology Research (9 papers) and Schizophrenia research and treatment (8 papers). Z. Janka is often cited by papers focused on Alzheimer's disease research and treatments (10 papers), Neuroscience and Neuropharmacology Research (9 papers) and Schizophrenia research and treatment (8 papers). Z. Janka collaborates with scholars based in Hungary, Australia and United Kingdom. Z. Janka's co-authors include Szabolcs Kéri, G. Benedek, Ogúz Kelemen, Anna Juhász, János Kálmán, Ágnes Rimanóczy, I. Szentistványi, David Jones, György Szekeres and Andrea Antal and has published in prestigious journals such as Brain Research, Neuroscience and Cellular and Molecular Life Sciences.

In The Last Decade

Z. Janka

49 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Z. Janka Hungary 18 474 251 215 197 167 53 1.0k
John A. Gurklis United States 19 369 0.8× 122 0.5× 193 0.9× 125 0.6× 150 0.9× 38 935
Kenneth L. Davis United States 13 516 1.1× 318 1.3× 268 1.2× 355 1.8× 304 1.8× 14 1.2k
Sylvain Grignon Canada 18 454 1.0× 176 0.7× 106 0.5× 202 1.0× 154 0.9× 45 989
Kaida Jiang China 21 490 1.0× 491 2.0× 188 0.9× 101 0.5× 209 1.3× 72 1.4k
Lian Yuan Cao China 19 522 1.1× 186 0.7× 231 1.1× 151 0.8× 336 2.0× 22 1.6k
Jun Ku Chung Canada 20 661 1.4× 410 1.6× 173 0.8× 184 0.9× 251 1.5× 53 1.3k
Ian Schapkaitz Australia 12 743 1.6× 96 0.4× 179 0.8× 136 0.7× 204 1.2× 14 1.5k
Christina M. Demopulos United States 17 878 1.9× 224 0.9× 196 0.9× 73 0.4× 187 1.1× 21 1.5k
Helmfried E. Klein Germany 18 374 0.8× 272 1.1× 114 0.5× 138 0.7× 112 0.7× 49 1.1k
D. Garver United States 18 416 0.9× 123 0.5× 226 1.1× 90 0.5× 282 1.7× 35 929

Countries citing papers authored by Z. Janka

Since Specialization
Citations

This map shows the geographic impact of Z. Janka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Z. Janka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Z. Janka more than expected).

Fields of papers citing papers by Z. Janka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Z. Janka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Z. Janka. The network helps show where Z. Janka may publish in the future.

Co-authorship network of co-authors of Z. Janka

This figure shows the co-authorship network connecting the top 25 collaborators of Z. Janka. A scholar is included among the top collaborators of Z. Janka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Z. Janka. Z. Janka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kálmán, János, Krassimira Garbett, Z. Janka, & Károly Mirnics. (2016). Human dermal fibroblasts in psychiatry research. Neuroscience. 320. 105–121. 31 indexed citations
3.
Lima, Luciana Moreira, Maria das Graçãs Carvalho Ferriani, Cláudia Natália Ferreira, et al.. (2010). Atheromatosis Extent in Coronary Artery Disease is not Correlated with Apolipoprotein-E Polymorphism and its Plasma Levels, but Associated with Cognitive Decline. Current Alzheimer Research. 7(6). 556–563. 13 indexed citations
4.
Álmos, P.Z., et al.. (2010). P03-20 - Correlations of Neurocognitive Visual Tests in Schizophrenia. European Psychiatry. 25(S1).
5.
Álmos, P.Z., Szatmár Horváth, Ágnes Czibula, et al.. (2008). H1 tau haplotype-related genomic variation at 17q21.3 as an Asian heritage of the European Gypsy population. Heredity. 101(5). 416–419. 13 indexed citations
6.
Kálmán, János, et al.. (2006). Unchanged rat brain amyloid precursor protein levels after exposure to benzodiazepines in vivo. European Journal of Anaesthesiology. 23(9). 772–775. 4 indexed citations
7.
Kéri, Szabolcs, Anna Juhász, Ágnes Rimanóczy, et al.. (2005). Habit Learning and the Genetics of the Dopamine D₃ Receptor: Evidence From Patients With Schizophrenia and Healthy Controls.. Behavioral Neuroscience. 119(3). 687–693. 41 indexed citations
8.
Pákáski, Magdolna, et al.. (2005). Imipramine and citalopram facilitate amyloid precursor protein secretion in vitro. Neurochemistry International. 47(3). 190–195. 39 indexed citations
9.
Kelemen, Ogúz, Szabolcs Kéri, Aviva Must, G. Benedek, & Z. Janka. (2004). No evidence for impaired ‘theory of mind’ in unaffected first‐degree relatives of schizophrenia patients. Acta Psychiatrica Scandinavica. 110(2). 146–149. 77 indexed citations
10.
Palotás, András, et al.. (2004). Haloperidol Attenuates β-Amyloid-Induced Calcium Imbalance in Human Fibroblasts. Skin Pharmacology and Physiology. 17(4). 195–199. 9 indexed citations
11.
Kéri, Szabolcs & Z. Janka. (2004). Critical evaluation of cognitive dysfunctions as endophenotypes of schizophrenia. Acta Psychiatrica Scandinavica. 110(2). 83–91. 79 indexed citations
12.
Antal, Andrea, Szabolcs Kéri, Zsigmond Tamás Kincses, et al.. (2003). Dopaminergic contributions to the visual categorization of natural scenes: evidence from Parkinson's disease. Journal of Neural Transmission. 110(7). 757–770. 14 indexed citations
13.
Kéri, Szabolcs, Ogúz Kelemen, G. Benedek, & Z. Janka. (2001). Different trait markers for schizophrenia and bipolar disorder: a neurocognitive approach. Psychological Medicine. 31(5). 915–922. 170 indexed citations
14.
Kéri, Szabolcs, Ogúz Kelemen, György Szekeres, et al.. (2000). Schizophrenics know more than they can tell: probabilistic classification learning in schizophrenia. Psychological Medicine. 30(1). 149–155. 71 indexed citations
15.
Kálmán, János, et al.. (2000). Serum and cerebrospinal fluid cystatin C levels in vascular and Alzheimer's dementia. Acta Neurologica Scandinavica. 101(4). 279–282. 21 indexed citations
16.
Kálmán, János, Bhalchandra J. Kudchodkar, Walter J. McConathy, et al.. (1999). Evaluation of Serum-Lipid-Related Cardiovascular Risk Factors in Alzheimer’s Disease. Dementia and Geriatric Cognitive Disorders. 10(6). 488–493. 28 indexed citations
17.
Kálmán, János, Anna Juhász, Albert Császár, et al.. (1998). Increased apolipoprotein E4 allele frequency is associated with vascular dementia in the Hungarian population. Acta Neurologica Scandinavica. 98(3). 166–168. 27 indexed citations
18.
Janka, Z., I. Szentistványi, Ágnes Rimanóczy, & Anna Juhász. (1980). The influence of external sodium and potassium on lithium uptake by primary brain cell cultures at ?therapeutic? lithium concentration. Psychopharmacology. 71(2). 159–163. 19 indexed citations
19.
Szentistványi, I., et al.. (1979). Comparison of lithium and sodium transports in primary cultures of dissociated brain cells.. PubMed. 25(5). 315–21. 10 indexed citations
20.
Szentistványi, I., et al.. (1979). Na-Dependent Li-transport in primary nerve cell cultures. Neuroscience Letters. 13(2). 157–161. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026